Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr
Products

Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches.

Rossari Biotech said that the acquisition will occur in multiple tranches.

It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025.

As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing.

Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run.

Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997.

It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA).

It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year.

Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal.

Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year.

Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round.

Image Source

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches. Rossari Biotech said that the acquisition will occur in multiple tranches. It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025. As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing. Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run. Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997. It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA). It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year. Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal. Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year. Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round. Image Source

Next Story
Infrastructure Energy

CCI Clears British Investment in ReNew Photovoltaics

The Competition Commission of India has approved British International Investment plc’s investment in ReNew Photovoltaics Private Limited. The UK government-owned development finance institution will invest in the Indian manufacturer of solar modules and solar cells by subscribing to its securities.This move aligns with India's broader clean energy goals. A detailed CCI order will follow...

Next Story
Infrastructure Urban

CCI Approves Coromandel's Stake Acquisition in NACL

The Competition Commission of India has approved Coromandel International Limited’s proposed acquisition of equity shares in NACL Industries Limited. Coromandel, a public listed agri-solutions provider, operates in crop nutrition, crop protection, active ingredients, and retail.NACL Industries, also a listed firm, offers a range of crop protection products including insecticides, fungicides, and herbicides. The acquisition aims to enhance Coromandel’s presence in the agrochemical sector. A detailed order is awaited. ..

Next Story
Infrastructure Urban

CCI Fines Publishers' Body Again for Anti-Competitive Practices

The Competition Commission of India (CCI) has penalised the Federation of Publishers’ and Booksellers’ Association in India (FPBAI) and three office-bearers for indulging in anti-competitive conduct. This includes fixing inflated conversion rates for imported books and journals, enforcing pricing terms on its members, and promoting only its approved suppliers to institutions. These practices violate Sections 3(3)(a), 3(3)(b) and 3(1) of the Competition Act.Despite an earlier cease and desist order from CCI, old circulars related to discount restrictions remained online and unwithdrawn. Con..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?